Uncommon Anomalous Biodistribution of <sup>18</sup>F-DCFPyL Prostate-Specific Membrane Antigen: A Case Series
Prostate cancer is assessed using the prostate-specific membrane antigen (PSMA) PET tracer 18F-DCFPyL. We present the cases of 4 patients who demonstrated abnormal biodistribution of 18F-DCFPyL, showing increased tracer retention in the blood pool and decreased accumulation in tissues with high PSMA
Authors
- Zachary Drew (ORCID: https://orcid.org/0000-0003-1277-4524)
- Dalveer Singh (ORCID: https://orcid.org/0000-0001-5509-8322)
- R. W. Ware
- Bosen Xie (ORCID: https://orcid.org/0009-0000-0479-9030)
- P.O. Jackson
- Theodore Lau
- Gavin C. Mackie
Institutions
- Sunshine Coast University Hospital (AU)
- Agriculture Victoria Services (Australia) (AU)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2025-05-15
- DOI
- https://doi.org/10.2967/jnumed.125.269614
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00